Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Authors:
- Guilherme PovalaGPGuilherme Povala
- Bruna BellaverBBBruna Bellaver
- Marco Antônio De BastianiMBMarco Antônio De Bastiani
- Wagner S. BrumWBWagner S. Brum
- Pamela C. L. FerreiraPFPamela C. L. Ferreira
- Andrei BiegerABAndrei Bieger
- Tharick A. PascoalTPTharick A. Pascoal
- Andrea L. BenedetABAndrea L. Benedet
- Diogo O. SouzaDSDiogo O. Souza
- Ricardo M. AraujoRARicardo M. Araujo
- Bruno ZattBZBruno Zatt
- Pedro Rosa-NetoPRPedro Rosa-Neto
Open Access
- 11 December 2021
- journal article
- research article
- Published by Springer Nature in Cell & Bioscience
- Vol. 11 (1) , 1-13
Abstract
Background: Changes in soluble amyloid-beta (Aβ) levels in cerebrospinal fluid (CSF) are detectable at early preclinical stages of Alzheimer’s disease (AD). However, whether Aβ levels can predict downstream AD pathological features in cognitively unimpaired (CU) individuals remains unclear. With this in mind, we aimed at investigating whether a combination of soluble Aβ isoforms can predict tau pathology (T+) and neurodegeneration (N+) positivity.Methods: We used CSF measurements of three soluble Aβ peptides (Aβ1–38, Aβ1–40and Aβ1–42) in CU individuals (n = 318) as input features in machine learning (ML) models aiming at predicting T+ and N+. Input data was used for building 2046 tuned predictive ML models with a nested cross-validation technique. Additionally, proteomics data was employed to investigate the functional enrichment of biological processes altered in T+ and N+ individuals.Results: Our findings indicate that Aβ isoforms can predict T+ and N+ with an area under the curve (AUC) of 0.929 and 0.936, respectively. Additionally, proteomics analysis identified 17 differentially expressed proteins (DEPs) in individuals wrongly classified by our ML model. More specifically, enrichment analysis of gene ontology biological processes revealed an upregulation in myelinization and glucose metabolism-related processes in CU individuals wrongly predicted as T+. A significant enrichment of DEPs in pathways including biosynthesis of amino acids, glycolysis/gluconeogenesis, carbon metabolism, cell adhesion molecules and prion disease was also observed.Conclusions: Our results demonstrate that, by applying a refined ML analysis, a combination of Aβ isoforms can predict T+ and N+ with a high AUC. CSF proteomics analysis highlighted a promising group of proteins that can be further explored for improving T+ and N+ prediction.Keywords
All Related Versions
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88882.345577/2019-01, 88887.336490/2019-00)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (312410/2018-2, 435642/2018-9)
- Instituto Serrapilheira (Serra-1912-31365)
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (30786.434.24734.23112017, 54392.632.30451.05032021)
- Canadian Institutes of Health Research (MOP-11-51-31, FRN, 152985)
- Alzheimer's Association (NIRG-12-92090, NIRP-12-259245)
- Santé (2020-VICO-279314)
This publication has 45 references indexed in Scilit:
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's DiseaseNew England Journal of Medicine, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Neuropathological Alterations in Alzheimer DiseaseCold Spring Harbor Perspectives in Medicine, 2011
- Neuropathology of Alzheimer's DiseaseMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010
- Alzheimer's Disease Neuroimaging Initiative (ADNI)Neurology, 2010
- Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's diseaseBrain, 2009
- Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s diseaseJournal of Neural Transmission, 2009
- Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the ElderlyArchives of Neurology, 2008
- Validation of amyloid-β peptides in CSF diagnosis of neurodegenerative dementiasMolecular Psychiatry, 2007
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000